| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/09/2007 | US7161009 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160918 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor (PAI-1) |
| 01/09/2007 | US7160917 Prepared by fermentation by microorganism Stachybotris; anticoagulants, anticarcinogenic, antitumor, antidiabetic, and antihypoxic agents; cardiovascular disorders, angina pectoris, septic shock, arteriosclerosis |
| 01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | US7160901 Antiproliferative agents; antitumor agents; kinase inhibitors |
| 01/09/2007 | US7160899 Use of at least one compound with neurotrophic activity and at least one adenosine A2A receptor antagonist for the manufacture of a medicament for the treatment, prevention or alleviation of Parkinson's disease in a subject |
| 01/09/2007 | US7160887 Aromatic amine derivatives, their production and use |
| 01/09/2007 | US7160854 Binaphthyl peptidomimetics for treating vancomycin resistant Staphylococcus aureas infections |
| 01/09/2007 | US7160684 Methods of selecting compounds for modulation of bladder function |
| 01/09/2007 | US7160556 Immediate release medicinal compositions for oral use |
| 01/09/2007 | US7160555 Antidiabetic agents |
| 01/09/2007 | CA2407538C Novel bicyclic compounds |
| 01/09/2007 | CA2169831C Cosmetic melanins |
| 01/09/2007 | CA2144293C Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/04/2007 | WO2007002314A2 Polymorphic forms of tegaserod maleate |
| 01/04/2007 | WO2007002181A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 01/04/2007 | WO2007001015A1 Process for production of optically active aminopentane derivative, intermediate in the process and process for production of the intermediate |
| 01/04/2007 | WO2007000339A1 Bicyclic derivatives as p38 kinase inhibitors |
| 01/04/2007 | WO2007000337A1 Bicyclic derivatives as p38 kinase inhibitors |
| 01/04/2007 | US20070004890 N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof |
| 01/04/2007 | US20070004806 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/04/2007 | US20070004757 Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 01/04/2007 | US20070004719 Inhibitors of cytosolic phospholipase A2 |
| 01/04/2007 | US20070004717 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(-4-hydroxy-1-oxo-hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-methylbenzonitrile |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | CA2613720A1 Bicyclic derivatives as p38 kinase inhibitors |
| 01/04/2007 | CA2613354A1 Non-nucleoside anti-hepacivirus agents and uses thereof |
| 01/04/2007 | CA2612290A1 Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate |
| 01/04/2007 | CA2612008A1 Bicyclic derivatives as p38 kinase inhibitors |
| 01/04/2007 | CA2611128A1 Novel indoline compounds |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1739073A1 New primary 2,3-disubstituted para-phenylendiamins and their use as oxidative colouring of keratinic fibers |
| 01/03/2007 | EP1737925A1 New organic luminescent element |
| 01/03/2007 | EP1737854A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR |
| 01/03/2007 | EP1737827A1 Process for preparing pyridazinone compounds |
| 01/03/2007 | EP1737821A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/03/2007 | EP1737820A1 Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives |
| 01/03/2007 | EP1737815A1 Thio-substituted biaryl-methanesulfinyl derivatives |
| 01/03/2007 | EP1737813A1 Androgen modulators |
| 01/03/2007 | EP1737812A1 Methods of amination |
| 01/03/2007 | EP1737811A1 Cetp inhibitors |
| 01/03/2007 | EP1362601B1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression |
| 01/03/2007 | EP1310487B1 Processes for preparation of bicyclic compounds and intermediates therefor |
| 01/03/2007 | EP1202963B1 Spla2 inhibitors |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | CN1890248A Novel compounds |
| 01/03/2007 | CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/03/2007 | CN1890214A Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 01/03/2007 | CN1890213A Process for the preparation of n-amino substituted heterocyclic compounds |
| 01/03/2007 | CN1889947A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/03/2007 | CN1887883A V-shaped conjugated light-absorbing organic salt compound and its use |
| 01/03/2007 | CN1887865A Synthesis of 3-substituted phenyl indole compound |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293057C Ethylenediamine derivatives |
| 01/03/2007 | CN1293054C Processes for preparation of bicyclic compounds and intermediates therefor |
| 01/03/2007 | CN1293053C 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157577 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors |
| 01/02/2007 | US7157489 HIV protease inhibitors |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157485 2S, 3aS, 7aS)-1-{(2S)-2 [(tert-Butoxycarbonyl)-amino]-propionyl}-octahydro-1H-indole-2-carboxylic acid; using, as sole sources of chirality, alanine starting material and a compound readily accessible from serine |
| 01/02/2007 | US7157484 Method for synthesissing (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof and the use thereof for perindopril synthesis |
| 01/02/2007 | US7157470 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/02/2007 | US7157463 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
| 01/02/2007 | CA2211839C Use of melatonin for treating patients suffering from drug addiction |
| 01/02/2007 | CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use |
| 01/02/2007 | CA2135709C Melatonin derivatives for use in treating sleep disorders |
| 12/28/2006 | WO2006137369A1 Reactive monomer and resin composition containing same |
| 12/28/2006 | WO2006137082A1 Process for industrially viable preparation of perindopril erbumine |
| 12/28/2006 | WO2006136606A2 Oxindole derivatives |
| 12/28/2006 | WO2006124902A3 Synthesis of salinosporamide a and analogues thereof |
| 12/28/2006 | WO2006082409A8 Tricyclic cytoprotective compounds |
| 12/28/2006 | WO2006055463A3 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 12/28/2006 | WO2006020664A3 Ammonolysis process for the preparation of intermediates for dpp iv inhibitors |
| 12/28/2006 | WO2005104711A3 Purification of progesterone receptor modulators |
| 12/28/2006 | US20060293353 Matrix metalloproteinase inhibitors |
| 12/28/2006 | US20060293313 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; shows high affinity for both the dopamine D2 receptor and the serotonin reuptake site, useful for treating central nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | DE102005030314A1 New triarylamine-derivates useful as hole transportation substance or luminescent substance in an organic electroluminescent device; and as hole transportation substance in an electrophotographic arrangement |
| 12/28/2006 | CA2612451A1 Oxindole derivatives |
| 12/27/2006 | EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
| 12/27/2006 | EP1735300A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 12/27/2006 | EP1735270A1 Diamino alcohols and their use as renin inhibitors |
| 12/27/2006 | EP1734951A2 Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1611098B1 Compounds having activity at 5ht2c receptor and uses thereof |
| 12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
| 12/27/2006 | EP1187806B1 Spermine:peptide-based surfactant compounds |
| 12/27/2006 | EP1149118B1 Method of producing derivatized polymers |